Procter & gamble co（PG.US AI Earnings Summary）
PG AI Earnings Summary (In-Depth)
2027 Q1 (Fiscal Year)
Core Highlights
- Stock Price Reaction: PROCTER & GAMBLE CO announced its fiscal 2027 Q1 earnings before the market opened on October 22, 2026. Driven by organic sales growth across all product lines and six major regions, along with a recovery in volume, the stock price surged 5.4% to 5.8% (reaching a high of $166.72) during intraday trading following the release, significantly easing market concerns over rising raw material and freight costs.
- Market Expectations: Both actual revenue and earnings for the quarter exceeded market expectations (Wall Street consensus estimates as cited in reports accompanying this quarter's transcript). Core EPS was $2.00, approximately 5.8% above market expectations; revenue reached $23.28B, exceeding expectations by about 2.0%. The core EPS beat was primarily driven by accelerated revenue from a 2.4 percentage point growth in volume, and 250 basis points of strong productivity improvements offsetting part of the cost pressures.
- Performance vs. Previous Guidance: Quarterly operating performance met or exceeded the upper end of the company's own guidance. Organic sales growth reached 4.0%, approximately 1.0 percentage point above the upper end of the 1% to 3% expectation range provided last quarter; free cash flow productivity reached 93%, exceeding the upper end of the 85% to 90% expectation range.
- In a Nutshell: Accelerated volume-driven organic growth across all product lines and six major regions demonstrated strong operational resilience, with the market responding with an intraday surge of 5.4% to 5.8%.
Quarterly Highlights
Broad-based acceleration in organic sales, with synchronized growth across six regions and ten categories, marking the most balanced quarter in recent years.
Core EPS approximately 5.8% above consensus: Core earnings per share (Non-GAAP) for the quarter was $2.00, up 1% year-over-year, and $0.11 higher than the Wall Street consensus estimate of $1.89 cited in reports accompanying the transcript. Key drivers for the beat included Q1 commodity cost impacts reflecting only about 5% of year-over-year pressure (compared to an 8% full-year estimate), and a $90M IEEPA tariff refund, which together created a unique margin buffer this quarter.
Organic sales growth of 4.0%, about 2 percentage points above the high end of full-year expectations: Growth structure was healthy, with volume growth of 2.4 percentage points as the main driver, pricing contributing 0.4 percentage points, and product mix (selling more high-margin products) contributing over 1 percentage point. This was a rare quarter where volume, price, and mix all made positive contributions simultaneously.
Greater China organic sales grew 8% YoY, marking the sixth consecutive quarter of positive growth: Pampers saw a trial surge driven by a competitor's supply disruption, growing nearly 50% YoY; SK-II grew 13% YoY. CFO Andre Schulten noted that even excluding the ~3 percentage point contribution from competitive factors, the China business maintained about 5% organic growth, showing continued structural improvement.
Market share recovery among U.S. customers, with 70% of brand-category combinations in top 50 customers maintaining or growing share: Compared to less than 10% in the first half of fiscal 2026 and about 50% in the second half, this quarter rose to over 70%. Management set a target of 80% or more by year-end, emphasizing weekly customer-level diagnostics and action plans.
Pampers Amore expected to exceed $100M in first-year U.S. sales: This premium diaper, combining proprietary skincare technology with cashmere-touch materials, focuses on the core insight of "fewer babies per family, more spend per baby." It has recorded one of the most successful new product launches at multiple retailers and driven overall Pampers market share growth.
Free cash flow productivity reached 93%, about 5.5 percentage points above the upper end of the full-year target: Free cash flow for the quarter was approximately $4.4B, with a full-year expectation of 85%~90%. The company returned $3.9B to shareholders this quarter, including $2.6B in dividends and $1.3B in share repurchases.
Fabric Care organic sales grew 4.8% YoY, expanding market share in both the U.S. and Europe: U.S. Fabric Care grew 4%, with North American market share up 70 basis points; Europe grew 5%, with share up 60 basis points. Innovation in Tide Boosted, Tide Evo, Gain liquid and single-dose, and Lux Edition fabric softeners all contributed to growth.
29 out of the top 50 category-country combinations maintained or grew market share, an improvement from 25 in the first half of the fiscal year: Management stated that about 60% of the category-country combination fixes are complete. Overall global market share remained flat year-over-year, indicating that intervention measures are gradually taking effect.